NCT00458705
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Clinical trial condition
Hemostatic Disorders
Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.
3,075 public trials
581 recruiting studies
Hemostatic Disorders trial results
NCT01459653
- Conditions
- Adnexal Diseases, Agranulocytosis, B-cell Lymphoma, +61 more
- Locations
-
- Sandoz Investigational Site Innsbruck, Austria
- Sandoz Investigational Site Kufstein, Austria
- Sandoz Investigational Site Leoben, Austria
- Sandoz Investigational Site Deurne, Belgium
Completed
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
NCT01748721
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +103 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Children's Hospital of Orange County Orange, California, United States
- University of California San Francisco Medical Center - Parnassus San Francisco, California, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
NCT00639054
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease, +15 more
- Locations
-
- Multiple Myeloma Research Laboratory, Dept Hematology, Cph Univ Hosp Rigshospitalet Copenhagen, Capital Region, Denmark
Completed
Cancer Stem Cells in Multiple Myeloma
NCT01820546
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Ankara University Hematology Unit Ankara, Turkey (Türkiye)
NCT00594126
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Baltimore, Maryland, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
Completed
Safety and Dose Study of GRN163L and Velcade to Treat Patients With Refractory or Relapsed Myeloma
NCT00718601
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Karmanos Cancer Center Detroit, Michigan, United States
- St. Vincent's Comprehensive Cancer Center New York, United States
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT00002818
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +51 more
- Locations
-
- Massey Cancer Center Richmond, Virginia, United States
NCT02435745
- Conditions
- Aneurysm, Aortic Aneurysm, Aortic Diseases, +26 more
- Locations
-
- Division of Pulmonology, University Hospital Zurich Zurich, Canton of Zurich, Switzerland
NCT00514371
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Local Institution Berkeley, California, United States
- Local Institution San Francisco, California, United States
- Local Institution Augusta, Georgia, United States
- Local Institution Baltimore, Maryland, United States